Richard D. Truesdell, Jr.
Lawyers
Filters
Hertz $425 million exchangeable senior notes offering
The 5.500% exchangeable senior notes are due 2030
MBX Biosciences $200 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Royalty Pharma $2 billion senior notes offering
We advised Royalty Pharma on its investment-grade notes offering
Alnylam Pharmaceuticals $661.25 million convertible senior notes offering
The 0% convertible notes are due 2028
Hamilton Lane $77.5 million follow-on offering
The shares are listed on Nasdaq
Match Group $700 million senior notes offering
The high-yield notes are due 2033
Circle $1.5 billion follow-on offering
We advised Circle on its first follow-on offering as a listed company on NYSE
Zoetis $1.85 billion senior notes offering
The investment-grade notes are due 2028 and 2035
Assurant $300 million senior notes offering
We advised Assurant on its investment-grade offering of senior notes
MSCI $1.25 billion notes offering
We advised MSCI on its debut investment-grade offering of senior notes